`

Tagged: IMP

IND submission’s main objective is to obtain approval from FDA to perform clinical trials of an investigational medicinal product (IMP) in humans in the US.

August 18th, 2020 | IMP

The IND requires very detailed product and development data such as information related to manufacturing, data from nonclinical studies, and previous clinical studies related to the IMP. IND also requires a comprehensive source of documentation including study reports. It follows the CTD structure developed by ICH and is mandatory to be submitted in the eCTD […]

Pin It on Pinterest